Dale DC - Search Results

1

Effect of endotoxin on serum granulocyte and granulocyte-macrophage colony-stimulating factor levels in dogs.

Dale DC, Lau S, Nash R, Boone T, Osborne W. Dale DC, et al. J Infect Dis. 1992 Apr;165(4):689-94. doi: 10.1093/infdis/165.4.689. J Infect Dis. 1992. PMID: 1372636

2

An adult dog with cyclic neutropenia treated by lentivirus- mediated delivery of granulocyte colony-stimulating factor.

Yanay O, Brzezinski M, Christensen J, Liggitt D, Dale DC, Osborne WR. Yanay O, et al. Among authors: dale dc. Hum Gene Ther. 2006 Apr;17(4):464-9. doi: 10.1089/hum.2006.17.464. Hum Gene Ther. 2006. PMID: 16610934

3

Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropenia.

Yanay O, Dale DC, Osborne WR. Yanay O, et al. Among authors: dale dc. Hum Gene Ther. 2012 Nov;23(11):1136-43. doi: 10.1089/hum.2012.045. Epub 2012 Sep 12. Hum Gene Ther. 2012. PMID: 22845776 Free PMC article.

4

A comparison of treatment of canine cyclic hematopoiesis with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF interleukin-3, and canine G-CSF.

Hammond WP, Boone TC, Donahue RE, Souza LM, Dale DC. Hammond WP, et al. Among authors: dale dc. Blood. 1990 Aug 1;76(3):523-32. Blood. 1990. PMID: 1696146 Free article.

5

Treatment of canine cyclic neutropenia by lentivirus-mediated G-CSF delivery.

Yanay O, Barry SC, Katen LJ, Brzezinski M, Flint LY, Christensen J, Liggitt D, Dale DC, Osborne WR. Yanay O, et al. Among authors: dale dc. Blood. 2003 Sep 15;102(6):2046-52. doi: 10.1182/blood-2002-12-3722. Epub 2003 May 15. Blood. 2003. PMID: 12750178 Free article.

6

Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.

Hübel K, Dale DC, Liles WC. Hübel K, et al. Among authors: dale dc. J Infect Dis. 2002 May 15;185(10):1490-501. doi: 10.1086/340221. Epub 2002 Apr 19. J Infect Dis. 2002. PMID: 11992286 Review.

7

Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens.

Liles WC, Huang JE, van Burik JA, Bowden RA, Dale DC. Liles WC, et al. Among authors: dale dc. J Infect Dis. 1997 Apr;175(4):1012-5. doi: 10.1086/513961. J Infect Dis. 1997. PMID: 9086172

8

Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.

Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. Gaviria JM, et al. Among authors: dale dc. J Infect Dis. 1999 Apr;179(4):1038-41. doi: 10.1086/314679. J Infect Dis. 1999. PMID: 10068606

9

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.

Root RK, Dale DC. Root RK, et al. Among authors: dale dc. J Infect Dis. 1999 Mar;179 Suppl 2:S342-52. doi: 10.1086/513857. J Infect Dis. 1999. PMID: 10081506 Review.

10

Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo.

Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. Gaviria JM, et al. Among authors: dale dc. J Infect Dis. 1999 May;179(5):1301-4. doi: 10.1086/314728. J Infect Dis. 1999. PMID: 10191242 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

324 results

Search Page